We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
441 result(s) found, displaying 171 to 180
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PIPERACILLIN/TAZOBACTAM KABI 2 g/0.25 g piperacillin (as sodium)/tazobactam (as sodium) 2 g/0.25 g powder for injection bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PIPERACILLIN/TAZOBACTAM KABI 4 g/0.5 g piperacillin (as sodium)/tazobactam (as sodium) 4 g/0.5 g powder for injection bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METRONIDAZOLE KABI metronidazole 500mg/100mL solution for injection bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Medical device electrical cable, general purpose.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GLYCOPHOS sodium glycerophosphate (as hydrate) 4.32 g/20 mL concentrated solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Platelet storage solution.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Bag, medical device, reusable.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VORICONAZOLE KABI voriconazole 200 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CHLORHEXIDINE 0.5% + ALCOHOL 70% KABI topical lotion bottle.
-
Prescription medicine registrationActive ingredients: flucloxacillin sodium monohydrate.